Amalgamated Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Amalgamated Financial’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$57K	Buy	+6,196	New	+$52.7K	﹤0.01%	2369

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Amalgamated Financial's DCPH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022: 6,196 shares worth $57K. The stake represents ﹤0.01% of the portfolio and ranks #2369 among its holdings.

123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Amalgamated Financial held 6,196 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $57K as of Q1 2022.
Deciphera Pharmaceuticals, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2369 holding.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.